CB46975-21 - 0x0000000000006A24
Healthy Males & Females
Refresh
* Stipend may pay up to reflected amount.
Start Date:
March 3, 2026 - 2:00pm
End Date:
April 1, 2026 - 9:30am
Study Details
Study Number: CB46975
Group Number: 21
Study Requirement: Healthy Normal Male and Female
Stipend: up to $12,750.00
Study Criteria
Age: 19 - 55
BMI: 18 - 32
Weight Restriction: minimum weight 0 lbs
Study Information
Indication: This investigational medication is being developed to treat atopic dermatitis.
Route of Administration: Oral
Blood Draws: 37
Study Schedule
Schedule Type: Long Term
Study Length: 22 - Night Stay & 1 Return
Screening Dates:
| Event Day | Event Date |
|---|---|
| Monday | 2/23/2026 |
| Tuesday | 2/24/2026 |
| Tuesday | 2/24/2026 |
| Friday | 2/27/2026 |
| Monday | 3/2/2026 |
Doctor Exam Dates:
| Event Day | Event Date |
|---|---|
| Monday | 2/23/2026 |
| Tuesday | 2/24/2026 |
| Tuesday | 2/24/2026 |
| Friday | 2/27/2026 |
| Monday | 3/2/2026 |
Study Dates:
| Event Type | Start Day | Start Date | End Day | End Date | Phase | Site |
|---|---|---|---|---|---|---|
| Check-In | Tuesday | 3/3/2026 2:00:00 PM | Wednesday | 3/25/2026 10:00:00 AM | 1 | Lincoln |
| Return | Wednesday | 4/1/2026 8:30:00 AM | Wednesday | 4/1/2026 9:30:00 AM | 1 | Lincoln |
